Skip to content
Next generation gelling fibre range

Exufiber® & Exufiber® Ag+

Highly exuding wounds are challenging to treat.

  • We understand that highly exuding wounds are challenging to treat.

    You may see exudate pooling, sloughy tissue and delayed healing due to the presence of biofilm. Open chronic wounds are at an increased risk of infection and can put additional demands on nurses’ time and total healthcare costs.

    Your patient’s wellbeing will also be affected. Their wound may be painful and they may feel embarrassment and anxiety from leakage.

    It is not the environment you want to see for optimum wound healing, nor what your patients want to feel.

It's time for change.

That is why we look at gelling fibres differently. Providing a wound healing solution that you want to see and that your patients can feel. A positive, shared experience for you and for them.

Contact us to learn more

Introducing Exufiber® & Exufiber® Ag+

  • See one-piece removal.

     

    Patients feel relieved.

    Exufiber®stays intact during use1 and removes cleanly and easily in one-piece2,3 so that you can see a wound bed without dressing residue or debris.

  • See the transfer of exudate.

     

    Patients feel comfort.

    Exufiber® dressings efficiently** transfer exudate from the wound bed8,9 to the secondary dressing. They can be left in place for up to seven days***, allowing undisturbed healing10,11. You will see less pooling2,3 and an optimal environment. Meaning your patients may feel more comfortable and confident.

  • See a cleaner wound bed.

     

    Patients feel less anxious.

    Exufiber® promotes autolytic debridement, helping to breakdown slough3 , and reducing the need for further intervention. You will see a wound bed ready for healing and your patients may feel less pain and anxiety at dressing change.

  • Davies P, McCarty S. An in-use product evaluation of a gelling fibre dressing in wound management. E-poster presentation at Wounds UK Conference, 2017, Harrogate, United Kingdom.

  • Surgical Materials Testing Laboratory. BS EN 13726-1:2002:Test methods for primary wound dressing. Mölnlycke Health Care. Data on file. 2014.

  • Davies P, McCarty S. An in-use product evaluation of a gelling fibre dressing in wound management. E-poster presentation at Wounds UK Conference, 2017, Harrogate, United Kingdom.

Exufiber in action

  • Transfers exudate effectively

    Dr. Paulo Alves shares patient cases highlighting how Exufiber effectively transfers exudate in cavity wounds.

  • Supports a clean wound bed

    Dr. Paulo Alves shares patient cases showing Exufiber supporting a clean wound bed.

  • Prevents the reformation of biofilm infections*

    Dr. Paulo Alves shares patient cases where he used Exufiber Ag+ to help prevent biofilm reformation.
    *Exufiber Ag+

Clinical evidence.

Best Practice Statement

Management of Cavity Wounds in Practice

Cavity wounds pose clinical challenges. Wounds UK’s new Best Practice Statement offers clear, evidence-based guidance to support healthcare professionals in delivering effective, patient-centred wound management.

Download Best Practice Statement

Clinical case studies

Randomised Control Trial

Efficacy of Exufiber dressings vs. leading competitor

A randomised, open-label, parallel-group, multicentre, comparative study to compare the efficacy and safety of Exufiber® with Aquacel® Extra™ dressings in exuding venous and mixed aetiology leg ulcers

Read the RCT

NHS Procurement codes.

  •   MPC / SKU Size (cm) Dressings per box PIP code NPC Code
    Exufiber 709900 5x5 10 394-4337 ELY818
    709901 10x10 10 394-4345 ELY819
    709903 15x15 10 394-4352 ELY820
    709905 4.5x10 10 394-4402 ELY848
    709906 4.5x20 10 394-4386 ELY850
    709907 4.5x30 10 394-4378 ELY845
    709904 20x30 5 394-4360 ELY821
    709908 1x45 5 413-0464 ELY843
    709909 2x45 5 401-0005 ELY844
    Exufiber Ag+ 603401 5x5 10 414-3418 ELY846
    603402 10x10 10 414-3426 ELY847
    603403 15x15 10 414-3434 ELY830
    603404 4.5x10 10 414-3442 ELY832
    603405 4.5x20 10 414-3459 ELY833
    603406 4.5x30 10 414-3467 ELY834
    603407 20x30 5 414-3475 ELY831
    603400 2x45 5 414-3400 ELY849

Learn more.

Contact Mölnkycke today to learn more about Exufiber®

Fill out the form to connect with a Mölnlycke representative to learn more about the difference you can see and the difference your patients can feel with Exufiber®.

Unfortunately, we are unable to partner with individuals who are not healthcare professionals. Please do not submit a form if you are not a healthcare professional.

You must be logged in to submit this form. If you are logged in and still cannot post, make sure "Do not track" in your browser settings is disabled.

Unfortunately, we are unable to partner with individuals who are not healthcare professionals. Please do not submit a form if you are not a healthcare professional.

Which product(s) would you like to learn more about?

References

    1. Davies P, McCarty S. An in-use product evaluation of a gelling fibre dressing in wound management. E-poster presentation at Wounds UK Conference, 2017, Harrogate, United Kingdom.
    2. Chadwick P, McCardle J. Open, non-comparative, multicenter post clinical study of the performance and safety of a gelling fibre wound dressing on diabetic foot ulcers. Journal of Wound Care 2016; 25(4): 290-300.
    3. Smet, S, Beele H, Saine, L, Suys E, Henrickx B. Open, non-comparative, multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fibre dressing as intended. Poster Presentation at European Pressure Ulcer Advisory Panel Conference, 2015, Ghent, Belgium.
    4. Bjarnsholt T, Eberlein T, Malone M, Schultz G. Management of wound biofilm Made Easy. London: Wounds International 2017
    5. Gil J et al. 2017. Evaluation of a Gelling Fiber Dressing with Silver to Eliminate MRSA Biofi lm Infections and Enhance the Healing. Poster presented at the Symposium on Advanced Wound Care Spring meeting/ Wound Healing Society (WHS) Annual Meeting 2017, Apr 05–09, 2017, San Diego, CA, USA.
    6. Davis S C, Li J, Gil J. Head C, Valdes J, Glinos G D, Solis M, Higa A, Pastar I. Preclinical evaluation of a novel silver gelling fiber dressing on 
      Pseudomonas aeruginosa in a porcine wound infection model. Wound Rep Reg, 27: 360-365 (2019)
    7. Mölnlycke Health Care. Exufiber® Ag+: Physical properties over time. Data on file. (2019).
    8. Mölnlycke Health Care. Data on file. (2018)
    9. Mölnlycke Health Care. Data on file. (2020)
    10.  Surgical Material Testing Laboratory BS EN 13726-1:2002: Test methods for primary wound dressings. Mölnlycke Health Care. Data on file. (2014).
    11. Mölnlycke Health Care. Data on file. (2014)

    *As part of a holistic biofilm management approach as per international guidelines (i.e. cleansing, debridement and reassessment)4

    **For Exufiber® Ag+ when exposed to a flow rate of 0.6ml/h at 40mmHg pressure for up to seven days7

    ***Exufiber® and Exufiber® Ag+ can be left in place for up to seven days depending on wound condition and clinical practice. In addition, Exufiber® can be left in place for up to 14 days on donor sites

    Aquacel and Aquacel Ag Extra are trademarks of ConvaTec Inc

Select country

Get knowledge, learn about our products, get support and more.

United Kingdom

No markets

Go to {{ currentMarket?.displayName }}

Find jobs, our financial reports and more.

Mölnlycke corporate

Are you a healthcare professional?

This webpage contains information that is only intended for healthcare professionals. By selecting ‘Yes, I am’ you confirm that you are a healthcare professional.

No, I am not a Health Care Professional